MELISSA BREADY: Open Payments
NPI 1528554938 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 41 payments from 9 companies in 2025. Trend: 2023 $1,002 · 2024 $703 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $262 |
| Janssen Biotech, Inc. | 10 | $164 |
| ABBVIE INC. | 9 | $149 |
| UCB, Inc. | 4 | $99 |
| GENZYME CORPORATION | 2 | $52 |
| Amgen Inc. | 3 | $51 |
| Organon LLC | 2 | $49 |
| LEO Pharma Inc. | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $30 |
Products named: ILUMYA, TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, OTEZLA, NEMLUVIO, ANZUPGO.
Industry payments across PA — which companies pay providers there.
